NEVIA

Downloadable mobile application software for providing and optimizing neuromodulation therapy for gut health; Software for managing gastrointestinal and inflammatory conditions through AI-guided transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Software for providing and tracking brain-gut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices.

Non-invasive wearable medical devices for therapeutic neuromodulation, namely, devices that apply simultaneous transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Crohn’s Disease, and ulcerative colitis; Medical apparatus featuring dual-modality vagus nerve stimulation and AI-powered sensor feedback for modulating immune function and reducing gut inflammation.

Providing digital health services in the field of gastroenterology, namely, personalized therapeutic support and remote monitoring for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) through AI-guided neuromodulation therapy; Medical consultation and monitoring services using transcutaneous cervical and auricular vagus nerve stimulation delivered via wearable devices and mobile applications; Health services integrating bioelectronic therapy, symptom tracking, and real-time treatment adjustment to support immune modulation and inflammation reduction.